<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3-antibodies-09-00020">
 <label>3.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alexandrova</surname>
    <given-names>G.I.</given-names>
   </name>
   <name>
    <surname>Maassab</surname>
    <given-names>H.F.</given-names>
   </name>
   <name>
    <surname>Kendal</surname>
    <given-names>A.P.</given-names>
   </name>
   <name>
    <surname>Medvedeva</surname>
    <given-names>T.E.</given-names>
   </name>
   <name>
    <surname>Egorov</surname>
    <given-names>A.Y.</given-names>
   </name>
   <name>
    <surname>Klimov</surname>
    <given-names>A.I.</given-names>
   </name>
   <name>
    <surname>Cox</surname>
    <given-names>N.J.</given-names>
   </name>
  </person-group>
  <article-title>Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates</article-title>
  <source>Vaccine</source>
  <year>1990</year>
  <volume>8</volume>
  <fpage>61</fpage>
  <lpage>64</lpage>
  <pub-id pub-id-type="doi">10.1016/0264-410X(90)90179-P</pub-id>
  <pub-id pub-id-type="pmid">2316285</pub-id>
 </element-citation>
</ref>
